S&P 500$7,609.78
+0.13%
2m
DOW 30$51,307.79
+0.45%
2m
NASDAQ 100$30,660.60
+0.48%
2m
Russell 2000$291.66
+0.93%
2m
Russell 1000$414.78
+0.21%
2m
S&P 400$3,754.68
+0.87%
2m
S&P 600$1,696.37
+0.88%
2m

SIGHT SCIENCES (SGHT)

NASDAQ

$4.35+$0.005 (+0.12%)

Price as of Jun 03, 2026 4:10 PM EDT

$264.4M
Market Cap
7.96%
1-Year Change
Medical Devices
Industry

Annual

Quarterly

	12/31/2025	12/31/2024	12/31/2023	12/31/2022
Income Statement
Total Operating Revenue	77.4M -3.13%	79.9M -1.47%	81.1M +13.63%	71.3M +45.70%
Cost of Revenue	10.7M -7.63%	11.6M -2.53%	11.9M -3.88%	12.4M +43.57%
Gross Profit	66.7M -2.37%	68.3M -1.29%	69.2M +17.31%	59.0M +46.16%
Sales and Marketing Expense	89.2M -11.57%	100.8M -7.41%	108.9M -9.30%	120.1M +57.59%
Research and Development Expense	-14.6M -18.81%	-18.0M +2.48%	-17.6M -23.20%	-22.9M +46.21%
Depreciation and Amortization Expense	487,000 -31.60%	712,000 +15.96%	614,000 -13.52%	710,000 +12.34%
Total Operating Expenses	103.8M -12.67%	118.8M -6.04%	126.4M -11.53%	142.9M +55.65%
Operating Profit	-37.1M -26.58%	-50.5M -11.77%	-57.3M -31.78%	-84.0M +63.09%
Interest Income	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Interest Expense	-5.1M +10.30%	-4.7M -13.79%	-5.4M +21.09%	-4.5M +2.29%
Interest Income and Expense and Net	-5.1M +10.30%	-4.7M -13.79%	-5.4M +21.09%	-4.5M +3.00%
Total Nonoperating Income and Expense	-148,000 +362.50%	-32,000 -100.44%	7.2M +225.62%	2.2M +132.12%
Income before Taxes	-38.4M -25.07%	-51.3M -7.51%	-55.4M -35.68%	-86.2M +37.31%
Income Taxes	10,000 -95.76%	236,000 +114.55%	110,000 +134.04%	47,000 -75.00%
Extraordinary Items	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Net Income	-38.4M -25.40%	-51.5M -7.27%	-55.5M -35.59%	-86.2M +36.98%
Net Income from Continuing Operations Applicable to Common	-38.4M -25.07%	-51.3M -7.51%	-55.4M -35.68%	-86.2M +37.31%
Basic EPS and Net Income	-0.74 -28.16%	-1.03 -9.65%	-1.14 -36.67%	-1.80 -23.73%
Diluted EPS and Net Income	-0.74 -28.16%	-1.03 -9.65%	-1.14 -36.67%	-1.80 -23.73%
Basic Weighted Average Shares	52.1M +4.02%	50.1M +3.10%	48.6M +1.63%	47.8M +78.98%
Diluted Weighted Average Shares	52.1M +4.02%	50.1M +3.10%	48.6M +1.63%	47.8M +78.98%
Balance Sheet
Cash and Cash Equivalents	92.0M -23.59%	120.4M -12.87%	138.1M -25.34%	185.0M -29.03%
Short-Term Investments	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash and Cash Equivalents and Short-Term Investments	92.0M -23.59%	120.4M -12.87%	138.1M -25.34%	185.0M -29.03%
Total Current Assets	112.7M -19.35%	139.8M -14.18%	162.9M -22.32%	209.7M -24.31%
Accumulated Depreciation	2.4M +14.01%	2.1M +29.44%	1.6M +13.46%	1.4M +19.10%
Property and Plant and Equipment and Net	1.6M +1.90%	1.6M -3.66%	1.6M +4.39%	1.6M +8.05%
Total Long-Term Assets	518,000 -5.82%	550,000 -19.35%	682,000 +223.22%	211,000 +4.46%
Total Assets	115.3M -19.28%	142.8M -14.29%	166.7M -21.79%	213.1M -23.95%
Income Taxes Payable	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Total Short-Term Debt	0 N/A	0 -100.00%	2.2M N/A	0 N/A
Total Current Liabilities	11.0M -28.71%	15.5M +26.25%	12.3M -31.23%	17.8M +31.94%
Total Long-Term Debt	40.3M +2.40%	39.4M +24.12%	31.7M -4.82%	33.3M +2.01%
Total Long-Term Liabilities	31,000 -93.70%	492,000 -80.13%	2.5M +32.62%	1.9M -2.71%
Total Liabilities	51.4M -7.16%	55.3M +19.12%	46.4M -12.38%	53.0M +10.23%
Retained Earnings	-384.7M +11.10%	-346.3M +17.47%	-294.8M +23.22%	-239.2M +56.37%
Total Stockholders Equity	63.9M -26.94%	87.5M -27.19%	120.2M -24.90%	160.1M -31.03%
Total Shares Outstanding	53.5M +5.02%	50.9M +3.68%	49.1M +1.73%	48.3M +1.67%
Cash Flow
Cash from Operating Activities	-29.7M +32.85%	-22.4M -52.63%	-47.2M -37.89%	-76.0M +44.59%
Capital Expenditures	224,000 -41.82%	385,000 -51.33%	791,000 -18.45%	970,000 +19.31%
Cash from Investing Activities	-224,000 -41.82%	-385,000 -51.33%	-791,000 -18.45%	-970,000 +19.31%
Dividends Paid	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash from Financing Activities	1.8M -63.92%	5.0M +349.64%	1.1M -11.54%	1.2M -99.51%
Financials Ratio
Gross Margin	86.17% +0.79%	85.50% +0.18%	85.34% +3.23%	82.67% N/A
Operating Margin	-47.95% -24.21%	-63.27% -10.46%	-70.66% -39.96%	-117.70% N/A
Return on Assets	-29.77% -10.56%	-33.29% +13.77%	-29.26% -16.33%	-34.97% N/A
Return on Equity	-50.74% +2.32%	-49.59% +25.11%	-39.64% -9.88%	-43.98% N/A
Revenue Growth	-3.13% +113.47%	-1.47% -110.77%	13.63% -70.17%	45.70% N/A
Current Ratio	10.22 +13.14%	9.04 -32.02%	13.29 +12.96%	11.77 N/A
Cash Ratio	8.34 +7.18%	7.78 -30.98%	11.27 +8.58%	10.38 N/A
Debt-to-Equity Ratio	0.63 +40.16%	0.45 +59.36%	0.28 +35.61%	0.21 N/A
Debt-to-Assets Ratio	0.35 +26.86%	0.28 +35.31%	0.20 +30.26%	0.16 N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow